Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Adolfsson

Showing results (31-40 of 168) with videos related to

Pageof 17
Sort By:
European Urology|February 7, 2006
The choice between a therapy-induced long-term symptom and shortened survival due to prostate cancerThomas Hopfgarten, Jan Adolfsson, Lars Henningsohn, et al.
Community Dentistry and Oral Epidemiology|December 12, 2003
Tobacco prevention in Swedish dental careAsgeir R Helgason, Karl E Lund, Jan Adolfsson, et al.
European Journal of Cancer (Oxford, England : 1990)|March 3, 2015
The risk of prostate cancer for men on aspirin, statin or antidiabetic medicationsTobias Nordström, Mark Clements, Robert Karlsson, et al.
Scandinavian Journal of Urology and Nephrology|October 25, 2006
Reliability of assessment of urgency and other symptoms indicating anal sphincter, large bowel or urinary dysfunctionMassoud Al-Abany, Asgeir R Helgason, Jan Adolfsson, et al.
BMC Medical Research Methodology|January 7, 2018
Effects of pre-notification, invitation length, questionnaire length and reminder on participation rate: a quasi-randomised controlled trialMarie Koitsalu, Martin Eklund, Jan Adolfsson, et al.
Scandinavian Journal of Urology and Nephrology|September 14, 2007
The Internet and prostate cancer patients: searching for and finding informationStefan Buntrock, Thomas Hopfgarten, Jan Adolfsson, et al.
International Journal of Technology Assessment in Health Care|September 21, 2006
Disseminating evidence from health technology assessment: the case of tobacco preventionSusanna Axelsson, Asgeir R Helgason, Karl E Lund, et al.
Plos One|March 21, 2015
Quantifying the evidence for the risk of metabolic syndrome and its components following androgen deprivation therapy for prostate cancer: a meta-analysisCecilia Bosco, Danielle Crawley, Jan Adolfsson, et al.
European Urology|September 28, 2011
Multiple events of fractures and cardiovascular and thromboembolic disease following prostate cancer diagnosis: results from the population-based PCBaSe SwedenMieke Van Hemelrijck, Hans Garmo, Lars Holmberg, et al.
BJU International|August 3, 2013
Risk of in-hospital complications after radical cystectomy for urinary bladder carcinoma: population-based follow-up study of 7608 patientsMieke van Hemelrijck, Andreas Thorstenson, Philip Smith, et al.
Pageof 17

Showing results (31-40 of 168) with videos related to

Sort By:
Pageof 17
European Urology|February 7, 2006
The choice between a therapy-induced long-term symptom and shortened survival due to prostate cancerThomas Hopfgarten, Jan Adolfsson, Lars Henningsohn, et al.
Community Dentistry and Oral Epidemiology|December 12, 2003
Tobacco prevention in Swedish dental careAsgeir R Helgason, Karl E Lund, Jan Adolfsson, et al.
European Journal of Cancer (Oxford, England : 1990)|March 3, 2015
The risk of prostate cancer for men on aspirin, statin or antidiabetic medicationsTobias Nordström, Mark Clements, Robert Karlsson, et al.
Scandinavian Journal of Urology and Nephrology|October 25, 2006
Reliability of assessment of urgency and other symptoms indicating anal sphincter, large bowel or urinary dysfunctionMassoud Al-Abany, Asgeir R Helgason, Jan Adolfsson, et al.
BMC Medical Research Methodology|January 7, 2018
Effects of pre-notification, invitation length, questionnaire length and reminder on participation rate: a quasi-randomised controlled trialMarie Koitsalu, Martin Eklund, Jan Adolfsson, et al.
Scandinavian Journal of Urology and Nephrology|September 14, 2007
The Internet and prostate cancer patients: searching for and finding informationStefan Buntrock, Thomas Hopfgarten, Jan Adolfsson, et al.
International Journal of Technology Assessment in Health Care|September 21, 2006
Disseminating evidence from health technology assessment: the case of tobacco preventionSusanna Axelsson, Asgeir R Helgason, Karl E Lund, et al.
Plos One|March 21, 2015
Quantifying the evidence for the risk of metabolic syndrome and its components following androgen deprivation therapy for prostate cancer: a meta-analysisCecilia Bosco, Danielle Crawley, Jan Adolfsson, et al.
European Urology|September 28, 2011
Multiple events of fractures and cardiovascular and thromboembolic disease following prostate cancer diagnosis: results from the population-based PCBaSe SwedenMieke Van Hemelrijck, Hans Garmo, Lars Holmberg, et al.
BJU International|August 3, 2013
Risk of in-hospital complications after radical cystectomy for urinary bladder carcinoma: population-based follow-up study of 7608 patientsMieke van Hemelrijck, Andreas Thorstenson, Philip Smith, et al.
Pageof 17